Loading
institutionsInstitution
Barbara Ann Karmanos Cancer Institute
Detroit's NCI comprehensive cancer centre, where the MCF-7 breast cancer cell line was derived in 1973, now part of McLaren Health Care.
Also called: KarmanosMichigan Cancer Foundation
Overview
Karmanos descends from the Michigan Cancer Foundation, where in 1973 Herbert Soule derived MCF-7, the oestrogen-receptor-positive breast cancer cell line that became the most studied cancer cell model in the world. NCI-designated since 1978, it is Wayne State University's cancer centre and, since 2014, part of McLaren Health Care, giving it a statewide network of cancer sites across Michigan. It has long run one of the larger academic phase 1 programmes and studies cancer in Detroit's predominantly Black population. Karmanos also operates the Detroit metropolitan SEER registry.
Location
Detroit, MI, US
Type
cancer center · Wayne State University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#170 · 31 points (0 Newsweek + 15 NCI + 16 from 8 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to The Barbara Ann Karmanos Cancer Institute, including child institutions. 498 works · 7,119 citations · 65% open access · 14% clinical trials · 1% reviews.
Oncology works per year
1282022
1372023
922024
852025
562026
Most works
- Anthony Frank Shields60 works
- Hirva Mansurali Mamdani44 works
- Abhinav Deol36 works
- Joanne Xiu28 works
- Emil Lou26 works
- Elisabeth I. Heath21 works
- Wolfgang Michael Korn21 works
- Dipenkumar Modi21 works
- Seongho Kim21 works
- Ammar W. Sukari20 works
Most cited
- Phase 1 trials
- Breast cancer biology (MCF-7 heritage)
- Population science (Detroit SEER)
Similar pages
- InstitutionUC Davis Comprehensive Cancer Center
Shares NCI-Designated Cancer Centers, Lab models that fail to predict what happens in patients, Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- InstitutionVCU Massey Comprehensive Cancer Center
Shares NCI-Designated Cancer Centers, Real-world evidence, Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- InstitutionUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Shares NCI-Designated Cancer Centers, Trials do not represent the people who get cancer, National Cancer Institute (NIH), HR-positive / HER2-negative breast cancer.
- PersonMitch Dowsett
Shares Estrogen receptor (ERα), Endocrine therapy (SERMs, AIs, SERDs), HR-positive / HER2-negative breast cancer.
- TreatmentDiethylstilbestrol
Shares Estrogen receptor (ERα), Endocrine therapy (SERMs, AIs, SERDs), HR-positive / HER2-negative breast cancer.
- InstitutionThe Jackson Laboratory Cancer Center
Shares NCI-Designated Cancer Centers, Lab models that fail to predict what happens in patients, National Cancer Institute (NIH).
- InstitutionO'Neal Comprehensive Cancer Center at UAB
Shares NCI-Designated Cancer Centers, Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- InstitutionCancer Center at Illinois
Shares NCI-Designated Cancer Centers, Lab models that fail to predict what happens in patients, National Cancer Institute (NIH).